Literature DB >> 7482569

Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice.

M Saulnier1, S Huang, M Aguet, B Ryffel.   

Abstract

The role of interferon-gamma (IFN gamma) in contact hypersensitivity induced by the haptens, oxazolone and 2,4,6-trinitrochlorobenzene (TNCB), was investigated in mice with a targeted disruption of the IFN gamma receptor (IFN gamma-R-/-). The 24-h ear-swelling response to oxazolone or TNCB in sensitized animals was not significantly reduced by the disruption of IFN gamma signalling. Dermal mononuclear infiltrates (MN) and epidermal microabscesses, however, were clearly diminished in the mutant mice. The hapten-induced upregulation of intercellular-adhesion molecule-1 (ICAM-1) and major histocompatibility complex (MHC) class I in IFN gamma-R-/- mice was smaller when compared to wild-type mice. It is concluded that oxazolone- and TNCB-induced contact hypersensitivity is partially dependent on a functional IFN gamma system. While the cutaneous oedema is IFN gamma-independent, the mononuclear cell infiltration and epidermal microabscess formation are at least partly IFN gamma-dependent. Therefore, reduced cellular infiltrates are likely due to a reduced upregulation of ICAM-1 and class I antigen expression in IFN gamma-R-/- mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482569     DOI: 10.1016/0300-483x(95)03101-k

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  13 in total

1.  Stress-induced enhancement of skin immune function: A role for gamma interferon.

Authors:  F S Dhabhar; A R Satoskar; H Bluethmann; J R David; B S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.

Authors:  Donggou He; Lizhi Wu; Hee Kyung Kim; Hui Li; Craig A Elmets; Hui Xu
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Ultraviolet B suppresses immunity by inhibiting effector and memory T cells.

Authors:  Sabita Rana; Scott Napier Byrne; Linda Joanne MacDonald; Carling Yan-Yan Chan; Gary Mark Halliday
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

Review 4.  Inflammatory and immune mechanisms in contact hypersensitivity (CHS) in rats.

Authors:  A Popov; I Mirkov; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 5.  Interleukin-17 and its expanding biological functions.

Authors:  Sheng Xu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2010-04-12       Impact factor: 11.530

6.  CD86 (B7-2), but not CD80 (B7-1), expression in the epidermis of transgenic mice enhances the immunogenicity of primary cutaneous Candida albicans infections.

Authors:  A A Gaspari; R Burns; A Nasir; D Ramirez; R K Barth; C G Haidaris
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice.

Authors:  H Yokozeki; M-H Wu; K Sumi; K Igawa; Y Miyazaki; I Katayama; K Takeda; S Akira; K Nishioka
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

8.  IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.

Authors:  Donggou He; Lizhi Wu; Hee Kyung Kim; Hui Li; Craig A Elmets; Hui Xu
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

9.  Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice.

Authors:  P D Rennert; P S Hochman; R A Flavell; D D Chaplin; S Jayaraman; J L Browning; Y X Fu
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity.

Authors:  J Kehren; C Desvignes; M Krasteva; M T Ducluzeau; O Assossou; F Horand; M Hahne; D Kägi; D Kaiserlian; J F Nicolas
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.